Manus Neurodynamica: Digital Pen that Detects Neuromotor Illnesses Gets Major Cash Injection

Manus Neurodynamica, a medical technology firm based in Edinburgh, has secured £750,000 in funding for its digital pen technology which provides an early warning of Parkinson's disease. The company says it intends to use the funding to grow its business, grow its product list, expand its team and move towards US clinical trials. The NeuroMotor Pen (NMP) uses a combination of sensors built into the digital pen with software and an analytical engine supported by a Decision Support System. Users can record and analyse limb and hand motion, enabling quantification of fine motor skill. Digital biomarkers are then created toThe post Digital Pen that Detects Neuromotor Illnesses Gets Major Cash Injection appeared first on FutureScot.